{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:42:00Z","timestamp":1774266120166,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,6,6]],"date-time":"2016-06-06T00:00:00Z","timestamp":1465171200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00262-016-1852-3","type":"journal-article","created":{"date-parts":[[2016,6,6]],"date-time":"2016-06-06T12:11:52Z","timestamp":1465215112000},"page":"215-221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunotherapy after hematopoietic stem cell transplantation using umbilical cord blood-derived products"],"prefix":"10.1007","volume":"66","author":[{"given":"Aurore","family":"Saudemont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Alejandro","family":"Madrigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,6]]},"reference":[{"key":"1852_CR1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1365-2567.2002.01412.x","volume":"106","author":"K Wing","year":"2002","unstructured":"Wing K, Karlsson H, Rudin A, Suri-Payer E (2002) Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology 106:190\u2013199","journal-title":"Immunology"},{"key":"1852_CR2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4049\/jimmunol.164.1.183","volume":"164","author":"AM Thornton","year":"2000","unstructured":"Thornton AM, Shevach E (2000) Suppressor effector function of CD4+ CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 164:183\u2013190","journal-title":"J Immunol"},{"key":"1852_CR3","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.clim.2004.04.003","volume":"112","author":"P Trzonkowski","year":"2004","unstructured":"Trzonkowski P, My\u015bliwska J, Dobyszuk A, My\u015bliwski A (2004) CD4+ CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol 112:258\u2013267","journal-title":"Clin Immunol"},{"key":"1852_CR4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.20051511","volume":"202","author":"F Ghiringhelli","year":"2005","unstructured":"Ghiringhelli F, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel L (2005) CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med 202:1075\u20131085","journal-title":"J Exp Med"},{"key":"1852_CR5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4049\/jimmunol.172.2.834","volume":"172","author":"K Nakamura","year":"2004","unstructured":"Nakamura K, Fuss I, Pedersen A, Harada N, Nawata H, Strober W (2004) TGF-beta 1 plays an important role in the mechanism of CD4+ CD25+ regulatory T cell activity in both humans and mice. J Immunol 172:834\u2013842","journal-title":"J Immunol"},{"key":"1852_CR6","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.4049\/jimmunol.166.5.3008","volume":"166","author":"O Annacker","year":"2001","unstructured":"Annacker O, Burlen-Defranoux O, Barbosa TC, Cumano A, Bandeira A (2001) CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol 166:3008\u20133018","journal-title":"J Immunol"},{"key":"1852_CR7","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.1952","volume":"11","author":"LW Collison","year":"2010","unstructured":"Collison LW, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ, Brown SA, Rehg JE, Jones ML, Ni HT, Artis D, Turk MJ, Vignali DA (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11:1093\u20131101","journal-title":"Nat Immunol"},{"key":"1852_CR8","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ni1536","volume":"8","author":"P Pandiyan","year":"2007","unstructured":"Pandiyan P, Ishihara S, Reed J, Lenardo MJ (2007) CD4+ CD25+ Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 8:1353\u20131362","journal-title":"Nat Immunol"},{"key":"1852_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fimmu.2012.00051.eCollection","volume":"3","author":"A Schmidt","year":"2012","unstructured":"Schmidt A, Oberle N, Krammer PH (2012) Molecular mechanisms of Treg-mediated T cell suppression. Front Immunol 3:51. doi: 10.3389\/fimmu.2012.00051.eCollection","journal-title":"Front Immunol"},{"key":"1852_CR10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","volume":"133","author":"P Trzonkowski","year":"2009","unstructured":"Trzonkowski P, Ju\u015bci\u0144ska J, Dobyszuk A, Krzystyniak A, Marek N, My\u015bliwska J, Hellmann A (2009) First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+ CD25+ CD127-T regulatory cells. Clin Immunol 133:22\u201326","journal-title":"Clin Immunol"},{"key":"1852_CR11","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","volume":"117","author":"M Ianni Di","year":"2011","unstructured":"Di Ianni M, Carotti A, Terenzi A, Castellino F, Bonifacio E, Del Papa B, Zei T, Ostini RI, Cecchini D, Aloisi T, Perruccio K, Ruggeri L, Balucani C, Pierini A, Sportoletti P, Aristei C, Falini B, Reisner Y, Velardi A, Aversa F, Martelli MF (2011) Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117:3921\u20133928","journal-title":"Blood"},{"key":"1852_CR12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","volume":"124","author":"MF Martelli","year":"2014","unstructured":"Martelli MF, Ruggeri L, Falzetti F, Carotti A, Terenzi A, Pierini A, Massei MS, Amico L, Urbani E, Del Papa B, Zei T, Iacucci Ostini R, Cecchini D, Tognellini R, Reisner Y, Aversa F, Falini B, Velardi A (2014) HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse. Blood 124:638\u2013644","journal-title":"Blood"},{"key":"1852_CR13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.coi.2011.06.006","volume":"23","author":"M Edinger","year":"2011","unstructured":"Edinger M, Hermann P (2011) Regulatory T cells in stem cell transplantation: strategies and first clinical experiences. Curr Opin Immunol 23:679\u2013684","journal-title":"Curr Opin Immunol"},{"key":"1852_CR14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jcyt.2014.11.005","volume":"17","author":"A Theil","year":"2015","unstructured":"Theil A, Oelschl\u00e4gel U, Maiwald A, D\u00f6hler D, O\u00dfmann D, Zenkel A, Wilhelm C, Middeke JM, Shayegi N, Trautmann-Grill K, von Bonin M, Platzbecker U, Ehninger G, Bonifacio E, Bornh\u00e4user M (2015) Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease. Cytotherapy 17:473\u2013486","journal-title":"Cytotherapy"},{"key":"1852_CR15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jim.2008.09.019","volume":"339","author":"D Figueroa-Tentori","year":"2008","unstructured":"Figueroa-Tentori D, Querol S, Dodi IA, Madrigal A, Duggleby R (2008) High purity and yield of natural tregs from cord blood using a single step selection method. J Immunol Methods 339:228\u2013235","journal-title":"J Immunol Methods"},{"key":"1852_CR16","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood-2006-06-027409","volume":"108","author":"P Hoffmann","year":"2006","unstructured":"Hoffmann P, Boeld TJ, Doser K, Piseshka B, Andreesen R, Edinger M (2006) Only the CD45RA+ subpopulation of CD4+ CD25 high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 108:4260\u20134267","journal-title":"Blood"},{"key":"1852_CR17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","volume":"30","author":"M Miyara","year":"2009","unstructured":"Miyara M, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30:899\u2013911","journal-title":"Immunity"},{"key":"1852_CR18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2567.2005.02186.x","volume":"115","author":"K Wing","year":"2005","unstructured":"Wing K, Sandstr\u00f6m K, Lundin SB, Suri-Payer E, Rudin A (2005) CD4+ CD25+ FOXP3+ regulatory T cells from human thymus and cord blood suppress antigen-specific T cell responses. Immunology 115:516\u2013525","journal-title":"Immunology"},{"key":"1852_CR19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/TP.0b013e31827722ed","volume":"95","author":"K Milward","year":"2013","unstructured":"Milward K, Hester J, Figueroa-Tentori D, Madrigal A, Wood KJ (2013) Multiple unit pooled umbilical cord blood is a viable source of therapeutic regulatory T cells. Transplantation 95:85\u201393","journal-title":"Transplantation"},{"key":"1852_CR20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/eji.200323701","volume":"33","author":"K Wing","year":"2003","unstructured":"Wing K, Kollberg G, Lundgren A, Harris RA, Rudin A, Lundin S, Suri-Payer E (2003) CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cells. Eur J Immunol 33:579\u2013587","journal-title":"Eur J Immunol"},{"key":"1852_CR21","doi-asserted-by":"publisher","first-page":"305859","DOI":"10.1155\/2008\/305859","volume":"2008","author":"W Fujimaki","year":"2008","unstructured":"Fujimaki W, Takahashi N, Ohnuma K, Nagatsu M, Kurosawa H, Yoshida S, Dang NH, Uchiyama T, Morimoto C (2008) Comparative study of regulatory T cell function of human CD25CD4 T cells from thymocytes, cord blood, and adult peripheral blood. Clin Dev Immunol 2008:305859. doi: 10.1155\/2008\/305859","journal-title":"Clin Dev Immunol"},{"key":"1852_CR22","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","volume":"117","author":"CG Brunstein","year":"2011","unstructured":"Brunstein CG, Cao Q, McKenna DH, Hippen KL, Curtsinger J, Defor T, Levine BL, June CH, Rubinstein P, McGlave PB, Blazar BR, Wagner JE (2011) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117:1061\u20131070","journal-title":"Blood"},{"issue":"8","key":"1852_CR23","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","volume":"127","author":"CG Brunstein","year":"2016","unstructured":"Brunstein CG, Miller JS, McKenna DH, Hippen KL, DeFor TE, Sumstad D, Curtsinger J, Verneris MR, MacMillan ML, Levine BL, Riley JL, June CH, Le C, Weisdorf DJ, McGlave PB, Blazar BR, Wagner JE (2016) Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile and clinical effect. Blood 127(8):1044\u20131051. doi: 10.1182\/blood-2015-06-653667","journal-title":"Blood"},{"key":"1852_CR24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcyt.2013.07.009","volume":"16","author":"S Parmar","year":"2014","unstructured":"Parmar S, Tung SS, Robinson SN, Rodriguez G, Cooper LJ, Yang H, Shah N, Yang H, Konopleva M, Molldrem JJ, Garcia-Manero G, Najjar A, Yvon E, McNiece I, Rezvani K, Savoldo B, Bollard CM, Shpall EJ (2014) Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease. Cytotherapy 16:90\u2013100","journal-title":"Cytotherapy"},{"issue":"8","key":"1852_CR25","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.bbmt.2013.06.004","volume":"19","author":"CG Brunstein","year":"2013","unstructured":"Brunstein CG, Blazar BR, Miller JS, Cao Q, Hippen KL, McKenna DH, Curtsinger J, McGlave PB, Wagner JE (2013) Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation. Biol Blood Marrow Transpl 19(8):1271\u20131273. doi: 10.1016\/j.bbmt.2013.06.004","journal-title":"Biol Blood Marrow Transpl"},{"key":"1852_CR26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/ajcp\/93.2.263","volume":"93","author":"PK Kotylo","year":"1990","unstructured":"Kotylo PK, Yoder MC, Engle WA, Bolinger CD (1990) Rapid analysis of lymphocyte subsets in cord blood. Am J Clin Pathol 93:263\u2013266","journal-title":"Am J Clin Pathol"},{"key":"1852_CR27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.humimm.2011.12.015","volume":"73","author":"M Luevano","year":"2012","unstructured":"Luevano M, Alnabhan R, Querol S, Khakoo S, Madrigal A, Saudemont A (2012) The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation. Hum Immunol 73:248\u2013257","journal-title":"Hum Immunol"},{"key":"1852_CR28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","volume":"22","author":"MA Cooper","year":"2001","unstructured":"Cooper MA, Caligiuri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22:633\u2013640","journal-title":"Trends Immunol"},{"key":"1852_CR29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/jir.1995.15.527","volume":"15","author":"J Gaddy","year":"1995","unstructured":"Gaddy J, Broxmeyer HE (1995) Cord blood natural killer cells are functionally and phenotypically immature but readily respond to interleukin-2 and interleukin-12. J Interf Cytokine Res 15:527\u2013536","journal-title":"J Interf Cytokine Res"},{"key":"1852_CR30","first-page":"377","volume":"4","author":"Y Wang","year":"2007","unstructured":"Wang Y, Zheng X, Wei H, Sun R, Tian Z (2007) High expression of NKG2A\/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity. Cell Mol Immunol 4:377\u2013382","journal-title":"Cell Mol Immunol"},{"key":"1852_CR31","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1203\/01.PDR.0000156501.55431.20","volume":"57","author":"JH Dalle","year":"2005","unstructured":"Dalle JH, Wagner E, Blagdon M, Champagne J, Champagne MA, Duval M (2005) Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections. Pediatr Res 57:649\u2013655","journal-title":"Pediatr Res"},{"key":"1852_CR32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcyt.2014.08.003","volume":"17","author":"R Alnabhan","year":"2014","unstructured":"Alnabhan R, Madrigal A, Saudemont A (2014) Differential activation of cord blood and peripheral blood natural killer cells by cytokines. Cytotherapy 17:73\u201385","journal-title":"Cytotherapy"},{"key":"1852_CR33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.bmt.1704086","volume":"32","author":"LJ Burns","year":"2003","unstructured":"Burns LJ, DeFor TE, Vesole DH, Repka TL, Blazar BR, Burger SR, Panoskaltsis-Mortari A, Keever-Taylor CA, Zhang MJ, Miller JS (2003) IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I\/II trial. Bone Marrow Transpl 32:177\u2013186","journal-title":"Bone Marrow Transpl"},{"key":"1852_CR34","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","volume":"295","author":"L Ruggeri","year":"2002","unstructured":"Ruggeri L, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295:2097\u20132100","journal-title":"Science"},{"key":"1852_CR35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.smim.2014.02.004","volume":"26","author":"F Locatelli","year":"2014","unstructured":"Locatelli F, Brescia L, Merli P (2014) Natural killer cells in the treatment of high-risk acute leukaemia. Semin Immunol 26:173\u2013179","journal-title":"Semin Immunol"},{"key":"1852_CR36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fimmu.2015.00264.eCollection","volume":"6","author":"A Domogala","year":"2015","unstructured":"Domogala A, Madrigal JA, Saudemont A (2015) Natural killer cell immunotherapy: from bench to bedside. Front Immunol 6:264. doi: 10.3389\/fimmu.2015.00264.eCollection","journal-title":"Front Immunol"},{"key":"1852_CR37","doi-asserted-by":"publisher","first-page":"e76781","DOI":"10.1371\/journal.pone.0076781.eCollection","volume":"8","author":"N Shah","year":"2013","unstructured":"Shah N, Martin-Antonio B, Yang H, Ku S, Lee DA, Cooper LJ, Decker WK, Li S, Robinson SN, Sekine T, Parmar S, Gribben J, Wang M, Rezvani K, Yvon E, Najjar A, Burks J, Kaur I, Champlin RE, Bollard CM, Shpall EJ (2013) Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity. PLoS One 8:e76781. doi: 10.1371\/journal.pone.0076781.eCollection","journal-title":"PLoS One"},{"issue":"10","key":"1852_CR38","doi-asserted-by":"publisher","first-page":"e0138623","DOI":"10.1371\/journal.pone.0138623.eCollection","volume":"10","author":"M Escobedo-Cousin","year":"2015","unstructured":"Escobedo-Cousin M, Jackson N, Laza-Briviesca R, Ariza-McNaughton L, Luevano M, Derniame S, Querol S, Blundell M, Thrasher A, Soria B, Cooper N, Bonnet D, Madrigal A, Saudemont A (2015) Natural killer cells improve hematopoietic stem cell engraftment by increasing stem cell clonogenicity in vitro and in a humanized mouse model. PLoS One 10(10):e0138623. doi: 10.1371\/journal.pone.0138623.eCollection","journal-title":"PLoS One"},{"key":"1852_CR39","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/bmt.2009.304","volume":"45","author":"SR Yoon","year":"2010","unstructured":"Yoon SR, Yang SH, Ahn KH, Lee JH, Lee JH, Kim DY, Kang YA, Jeon M, Seol M, Ryu SG, Chung JW, Choi I, Lee KH (2010) Generation of donor natural killer cells from CD34(+) progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study. Bone Marrow Transpl 45:1038\u20131046","journal-title":"Bone Marrow Transpl"},{"key":"1852_CR40","doi-asserted-by":"publisher","first-page":"e9221","DOI":"10.1371\/journal.pone.0009221","volume":"5","author":"J Spanholtz","year":"2010","unstructured":"Spanholtz J, Eissens D, Preijers F, van der Meer A, Joosten I, Schaap N, de Witte TM, Dolstra H (2010) High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy. PLoS One 5:e9221. doi: 10.1371\/journal.pone.0009221","journal-title":"PLoS One"},{"key":"1852_CR41","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1182\/blood-2006-04-020198","volume":"108","author":"B Grzywacz","year":"2006","unstructured":"Grzywacz B, Sikora M, Oostendorp RA, Dzierzak EA, Blazar BR, Miller JS, Verneris MR (2006) Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood 108:3824\u20133833","journal-title":"Blood"},{"key":"1852_CR42","doi-asserted-by":"publisher","first-page":"e87086","DOI":"10.1371\/journal.pone.0087086.eCollection","volume":"9","author":"M Luevano","year":"2014","unstructured":"Luevano M, Domogala A, Blundell M, Jackson N, Pedroza-Pacheco I, Derniame S, Escobedo-Cousin M, Querol S, Thrasher A, Madrigal A, Saudemont A (2014) Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cells. PLoS One 9:e87086. doi: 10.1371\/journal.pone.0087086.eCollection","journal-title":"PLoS One"},{"key":"1852_CR43","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/sj.leu.2403524","volume":"18","author":"JR Passweg","year":"2004","unstructured":"Passweg JR, Meyer-Monard S, Heim D, Stern M, K\u00fchne T, Favre G, Gratwohl A (2004) Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation. Leukemia 18:1835\u20131838","journal-title":"Leukemia"},{"key":"1852_CR44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bcmd.2004.08.013","volume":"33","author":"U Koehl","year":"2004","unstructured":"Koehl U, Esser R, Zimmermann S, Gr\u00fcttner HP, Tonn T, Seidl C, Seifried E, Klingebiel T, Schwabe D (2004) IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation. Blood Cells Mol Dis 33:261\u2013266","journal-title":"Blood Cells Mol Dis"},{"key":"1852_CR45","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","volume":"105","author":"JS Miller","year":"2005","unstructured":"Miller JS, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, McKenna D, Le C, Defor TE, Burns LJ, Orchard PJ, Blazar BR, Wagner JE, Slungaard A, Weisdorf DJ, Okazaki IJ, McGlave PB (2005) Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 105:3051\u20133057","journal-title":"Blood"},{"key":"1852_CR46","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.2009.24.4590","volume":"28","author":"JE Rubnitz","year":"2010","unstructured":"Rubnitz JE, Ribeiro RC, Pounds S, Rooney B, Bell T, Pui CH, Leung W (2010) NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia. J Clin Oncol 28:955\u2013959","journal-title":"J Clin Oncol"},{"key":"1852_CR47","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00262-010-0896-z","volume":"59","author":"V Bachanova","year":"2010","unstructured":"Bachanova V, McKenna DH, Curtsinger J, Panoskaltsis-Mortari A, Lindgren BR, Cooley S, Weisdorf D, Miller JS (2010) Allogeneic natural killer cells for refractory lymphoma. Cancer Immunol Immunother 59:1739\u20131744","journal-title":"Cancer Immunol Immunother"},{"key":"1852_CR48","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood-2011-01-329508","volume":"118","author":"A Curti","year":"2011","unstructured":"Curti A, D\u2019Addio A, Bontadini A, Dan E, Motta MR, Trabanelli S, Giudice V, Urbani E, Martinelli G, Paolini S, Fruet F, Isidori A, Parisi S, Bandini G, Baccarani M, Velardi A, Lemoli RM (2011) Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. Blood 118:3273\u20133279","journal-title":"Blood"},{"key":"1852_CR49","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/bmt.2012.162","volume":"48","author":"M Stern","year":"2013","unstructured":"Stern M, Meyer-Monard S, Esser R, Tonn T, Soerensen J, Paulussen M, Gratwohl A, Klingebiel T, Bader P, Tichelli A, Schwabe D, Koehl U (2013) Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers. Bone Marrow Transpl 48:433\u2013438","journal-title":"Bone Marrow Transpl"},{"key":"1852_CR50","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1182\/blood-2013-10-532531","volume":"123","author":"V Bachanova","year":"2014","unstructured":"Bachanova V, Defor TE, Verneris MR, Zhang B, McKenna DH, Curtsinger J, Panoskaltsis-Mortari A, Lewis D, Hippen K, McGlave P, Weisdorf DJ, Blazar BR, Miller JS (2014) Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein. Blood 123:3855\u20133863","journal-title":"Blood"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1852-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-016-1852-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1852-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1852-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:48:23Z","timestamp":1498319303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-016-1852-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,6]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1852"],"URL":"https:\/\/doi.org\/10.1007\/s00262-016-1852-3","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,6]]}}}